Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objectives are to assess the efficacy (as measured by the reduction of the signs and symptoms of RA) and the safety and tolerability of JNJ-39758979 at doses of 10, 30, 100, or 300 mg/d compared with placebo in subjects with active RA despite concomitant methotrexate (MTX) therapy.
Inclusion criteria
- Rheumatoid Arthritis